Glenmark Pharmaceuticals has been granted final abbreviated new drug approvals (ANDA’s) from the United States Food and Drug Administration (USFDA) for Zolmitriptan Tablets, 2.5 and 5mg and Zolmitriptan Orally Disintegrating Tablets, 2.5 and 5mg. The pharma major will commence distribution of the product immediately.
No comments:
Post a Comment